Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v3.24.4
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Dec. 28, 2024
Dec. 30, 2023
OPERATING ACTIVITIES    
Net income (loss) $ (38,928) $ (550,574)
Income (loss) from discontinued operations, net of tax (258,519) 55,779
Income (loss) from continuing operations, net of tax 219,591 (606,353)
Adjustments to reconcile net loss to cash provided by operating activities:    
Impairment of goodwill and intangible assets 51,000 257,096
Depreciation and amortization 186,468 222,746
Reduction in the carrying amount of right-of-use assets 266,823 272,145
Stock-based compensation 52,619 43,576
Provision for doubtful accounts 14,178 7,157
Pension expense in excess of (less than) contributions 4,276 (10,691)
Deferred income taxes (15,014) (258,284)
Write-off of income tax receivables and interest 0 921,409
Other, net (15,993) (10,280)
Changes in operating assets and liabilities:    
Accounts receivable (126,720) 301,500
Inventories (135,156) 145,836
Accounts payable 228,241 40,120
Income taxes (66,172) (203,261)
Accrued liabilities 177,794 177,632
Operating lease right-of-use assets and liabilities (262,746) (269,819)
Other assets and liabilities 30,356 (55,358)
Cash provided by operating activities - continuing operations 609,545 975,171
Cash provided by operating activities - discontinued operations 26,747 130,576
Cash provided by operating activities 636,292 1,105,747
INVESTING ACTIVITIES    
Proceeds from sale of business, net of cash sold 1,485,951 0
Proceeds from sale of assets 88,062 381
Capital expenditures (64,299) (114,539)
Software purchases (29,202) (50,478)
Other, net (30,026) (19,862)
Cash provided (used) by investing activities - continuing operations 1,450,486 (184,498)
Cash used by investing activities - discontinued operations (4,413) (7,496)
Cash provided (used) by investing activities 1,446,073 (191,994)
FINANCING ACTIVITIES    
Net increase (decrease) in short-term borrowings (251,131) 443,494
Payments on long-term debt (1,000,829) (907,926)
Payment of debt issuance costs 0 (576)
Cash dividends paid (105,094) (268,155)
Proceeds from issuance of Common Stock, net of payments for tax withholdings (2,628) (2,603)
Cash used by financing activities (1,359,682) (735,766)
Effect of foreign currency rate changes on cash, cash equivalents and restricted cash (28,331) (4,984)
Net change in cash, cash equivalents and restricted cash 694,352 173,003
Cash, cash equivalents and restricted cash – beginning of year 676,957 816,319
Cash, cash equivalents and restricted cash – end of period 1,371,309 989,322
Balances per Consolidated Balance Sheets:    
Cash and cash equivalents 1,369,376 975,937
Other current assets 1,933 1,186
Current and other assets of discontinued operations 0 12,190
Other assets 0 9
Total cash, cash equivalents and restricted cash $ 1,371,309 $ 989,322